Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Randomized ZUMA‑7 Study of Axi-Cel vs. Standard‑of-Care Therapy in R/R LBCL"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jason Westin
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Jason Westin
1,511 views
June 7, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology